These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28668952)

  • 1. Myeloperoxidase Levels and Its Product 3-Chlorotyrosine Predict Chronic Kidney Disease Severity and Associated Coronary Artery Disease.
    Afshinnia F; Zeng L; Byun J; Gadegbeku CA; Magnone MC; Whatling C; Valastro B; Kretzler M; Pennathur S;
    Am J Nephrol; 2017; 46(1):73-81. PubMed ID: 28668952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloperoxidase-catalyzed 3-chlorotyrosine formation in dialysis patients.
    Himmelfarb J; McMenamin ME; Loseto G; Heinecke JW
    Free Radic Biol Med; 2001 Nov; 31(10):1163-9. PubMed ID: 11705694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbial Product Predicts Cardiovascular Risk in Chronic Kidney Disease Patients.
    Jadoon A; Mathew AV; Byun J; Gadegbeku CA; Gipson DS; Afshinnia F; Pennathur S;
    Am J Nephrol; 2018; 48(4):269-277. PubMed ID: 30326477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study.
    Mafune A; Iwamoto T; Tsutsumi Y; Nakashima A; Yamamoto I; Yokoyama K; Yokoo T; Urashima M
    Clin Exp Nephrol; 2016 Oct; 20(5):731-739. PubMed ID: 26676906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous measurement of protein-bound 3-chlorotyrosine and homocitrulline by LC-MS/MS after hydrolysis assisted by microwave: application to the study of myeloperoxidase activity during hemodialysis.
    Delporte C; Franck T; Noyon C; Dufour D; Rousseau A; Madhoun P; Desmet JM; Serteyn D; Raes M; Nortier J; Vanhaeverbeek M; Moguilevsky N; Nève J; Vanhamme L; Van Antwerpen P; Zouaoui Boudjeltia K
    Talanta; 2012 Sep; 99():603-9. PubMed ID: 22967600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum bone morphogenetic protein 4 in patients with chronic kidney disease and coronary artery disease.
    Stahls PF; Lightell DJ; Moss SC; Goldman CK; Woods TC
    J Cardiovasc Transl Res; 2013 Apr; 6(2):232-8. PubMed ID: 23208015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of renal function on mean platelet volume and its relationship with coronary artery disease: A single-centre cohort study.
    Verdoia M; Barbieri L; Schaffer A; Bellomo G; Marino P; De Luca G;
    Thromb Res; 2016 May; 141():139-44. PubMed ID: 27039166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Troponin in diabetic patients with and without chronic coronary artery disease.
    Segre CA; Hueb W; Garcia RM; Rezende PC; Favarato D; Strunz CM; Sprandel Mda C; Roggério A; Carvalho AL; Maranhão RC; Ramires JA; Kalil Filho R
    BMC Cardiovasc Disord; 2015 Jul; 15():72. PubMed ID: 26195004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between adipokine and myeloperoxidase levels in patients with coronary artery disease.
    Basati G; Emami Razavi A; Abdi S; Sarrafzadegan N
    Acta Med Iran; 2015; 53(1):25-9. PubMed ID: 25597601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
    Gregg LP; Adams-Huet B; Li X; Colbert G; Jain N; de Lemos JA; Hedayati SS
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MCP-1 and soluble TWEAK levels are independently associated with coronary artery disease severity in patients with chronic kidney disease.
    Akdoğan MF; Azak A; Denizli N; Huddam B; Koçak G; Gücün M; Tatlısu MA; Demirci R; Yılmaz B; Dikeç M; Bakırtaş M; Akdağ İ; Duranay M
    Ren Fail; 2015; 37(8):1297-302. PubMed ID: 26382008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction.
    Mocatta TJ; Pilbrow AP; Cameron VA; Senthilmohan R; Frampton CM; Richards AM; Winterbourn CC
    J Am Coll Cardiol; 2007 May; 49(20):1993-2000. PubMed ID: 17512353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloperoxidase in chronic kidney disease: role of visceral fat.
    Tsai MS; Shaw HM; Li YJ; Lin MT; Lee WT; Chan KS
    Nephrology (Carlton); 2014 Mar; 19(3):136-42. PubMed ID: 24330098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased trefoil factor 2 levels in patients with chronic kidney disease.
    Lebherz-Eichinger D; Tudor B; Ankersmit HJ; Reiter T; Haas M; Einwallner E; Roth-Walter F; Krenn CG; Roth GA
    PLoS One; 2017; 12(3):e0174551. PubMed ID: 28355260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications.
    Morena M; Jaussent I; Dupuy AM; Bargnoux AS; Kuster N; Chenine L; Leray-Moragues H; Klouche K; Vernhet H; Canaud B; Cristol JP
    Nephrol Dial Transplant; 2015 Aug; 30(8):1345-56. PubMed ID: 25854266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease.
    Yunoki K; Naruko T; Inaba M; Inoue T; Nakagawa M; Sugioka K; Ohsawa M; Iwasa Y; Komatsu R; Itoh A; Haze K; Yoshiyama M; Becker AE; Ueda M
    Atherosclerosis; 2013 Dec; 231(2):308-14. PubMed ID: 24267244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease.
    Wang G; Mathew AV; Yu H; Li L; He L; Gao W; Liu X; Guo Y; Byun J; Zhang J; Chen YE; Pennathur S
    PLoS One; 2018; 13(3):e0193782. PubMed ID: 29505607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Chlorotyrosine as a marker of protein damage by myeloperoxidase in tracheal aspirates from preterm infants: association with adverse respiratory outcome.
    Buss IH; Senthilmohan R; Darlow BA; Mogridge N; Kettle AJ; Winterbourn CC
    Pediatr Res; 2003 Mar; 53(3):455-62. PubMed ID: 12595594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations among chronic kidney disease, high total p-cresylsulfate and major adverse cardiac events.
    Wang CP; Lu LF; Yu TH; Hung WC; Chiu CA; Chung FM; Hsu CC; Lu YC; Lee YJ; Houng JY
    J Nephrol; 2013; 26(1):111-8. PubMed ID: 22460182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development, optimization and validation of an absolute specific assay for active myeloperoxidase (MPO) and its application in a clinical context: role of MPO specific activity in coronary artery disease.
    Trentini A; Rosta V; Spadaro S; Bellini T; Rizzo P; Vieceli Dalla Sega F; Passaro A; Zuliani G; Gentili V; Campo G; Cervellati C
    Clin Chem Lab Med; 2020 Sep; 58(10):1749-1758. PubMed ID: 32031967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.